DOWLING & YAHNKE LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 29 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$8,000
+100.0%
22,8700.0%0.00%
Q1 2020$4,000
-20.0%
22,8700.0%0.00%
Q4 2019$5,0000.0%22,8700.0%0.00%
Q3 2019$5,000
-16.7%
22,8700.0%0.00%
Q2 2019$6,000
-45.5%
22,8700.0%0.00%
-100.0%
Q1 2019$11,000
-15.4%
22,8700.0%0.00%0.0%
Q4 2018$13,000
-23.5%
22,8700.0%0.00%0.0%
Q3 2018$17,000
+13.3%
22,8700.0%0.00%0.0%
Q2 2018$15,000
+87.5%
22,8700.0%0.00%0.0%
Q1 2018$8,000
-46.7%
22,8700.0%0.00%0.0%
Q4 2017$15,000
+15.4%
22,8700.0%0.00%0.0%
Q3 2017$13,000
-53.6%
22,8700.0%0.00%
-66.7%
Q2 2017$28,000
-20.0%
22,8700.0%0.00%
-25.0%
Q1 2017$35,000
+75.0%
22,8700.0%0.00%
+100.0%
Q4 2016$20,000
-35.5%
22,8700.0%0.00%
-50.0%
Q3 2016$31,000
-22.5%
22,8700.0%0.00%
-20.0%
Q2 2016$40,000
-13.0%
22,8700.0%0.01%
-16.7%
Q1 2016$46,000
-37.8%
22,8700.0%0.01%
-33.3%
Q4 2015$74,00022,8700.01%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 8,147,650$2,864,0000.84%
Consonance Capital Management LP 37,000,000$13,006,0000.78%
CVI Holdings, LLC 2,850,477$1,002,0000.37%
SABBY MANAGEMENT, LLC 972,285$342,0000.07%
J. Goldman & Co LP 2,150,385$756,0000.05%
Virtu Financial LLC 668,600$235,0000.03%
ARDSLEY ADVISORY PARTNERS LP 130,000$46,0000.01%
Summit X, LLC 68,200$24,0000.01%
OXFORD FINANCIAL GROUP, LTD. LLC 107,200$38,0000.01%
Laidlaw Wealth Management LLC 28,000$10,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders